BIOVEST INTERNATIONAL INC 4

4 · BIOVEST INTERNATIONAL INC · Filed Aug 23, 2013

Form 4

Period: 2013-07-09

Chief Scientific Officer

Transactions

Other
COMMON STOCK
2013-07-09−55,800→ 0 total
Other
Stock Option (Right to Buy)
2013-07-09−33,540→ 0 total
Exercise: $0.56→ Common Stock (33,540 underlying)
Other
Stock Option (Right to Buy)
2013-07-09−250,000→ 0 total
Exercise: $0.06→ Common Stock (250,000 underlying)
Other
Stock Option (Right to Buy)
2013-07-09−424,200→ 0 total
Exercise: $0.57→ Common Stock (424,200 underlying)
Other
Stock Option (Right to Buy)
2013-07-09−512,393→ 0 total
Exercise: $0.18→ Common Stock (512,393 underlying)
Other
Stock Option (Right to Buy)
2013-07-09−60,000→ 0 total
Exercise: $0.50→ Common Stock (60,000 underlying)
Other
Stock Option (Right to Buy)
2013-07-09−19,375→ 0 total
Exercise: $0.70→ Common Stock (19,375 underlying)
Other
Stock Option (Right to Buy)
2013-07-09−33,558→ 0 total
Exercise: $0.60→ Common Stock (33,558 underlying)
Other
Stock Option (Right to Buy)
2013-07-09−850,000→ 0 total
Exercise: $0.69→ Common Stock (850,000 underlying)
Other
Stock Option (Right to Buy)
2013-07-09−150,000→ 0 total
Exercise: $0.92→ Common Stock (150,000 underlying)

Footnotes (1)

[F1]Pursuant to the First Amended Plan of Reorganization under Chapter 11 of the Bankruptcy Code (as modified, amended and supplemented, the ?Plan?) of Biovest International, Inc. (the "Company"), which was confirmed by the United States Bankruptcy Court for the Middle District of Florida, Tampa Division on June 28, 2013 and became effective on July 9, 2013 (the "Effective Date"), all equity interests of the Company, and options to purchase such equity interests, that were outstanding prior to the Effective Date were cancelled without consideration on the Effective Date.

Documents

1 file